Factors Contributing to the Emergence and Spread of Antibiotics Resistance in Salmonella Species by Akinyemi, Kabiru Olusegun & Ajoseh, Samuel Oluwasegun
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
Chapter 6
Factors Contributing to the Emergence and Spread of
Antibiotics Resistance in Salmonella Species
Kabiru Olusegun Akinyemi and
Samuel Oluwasegun Ajoseh
Additional information is available at the end of the chapter
http://dx.doi.org/10.5772/67701
© 2016 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons 
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, 
and reproduction in any medium, provided the original work is properly cited. 
Kabiru Olusegun Akinyemi and Samuel 
Oluwasegun Ajoseh
Additional information is available at the end of the chapter
Abstract
Salmonella, a genus of the family Enterobacteriaceae with over 2450 species, has been respon-
sible for diseases ranging from non-typhoidal salmonellosis to typhoidal salmonellosis.  
Several groups of antibiotics such as β-lactams, aminoglycosides, tetracyclines, quinolones, 
cephalosporins and sulfonamides are used against Salmonella species. Many Salmonella 
species had developed resistance to several antibiotics over the years. Two major groups of 
mechanism of resistance demonstrated by this pathogen are (1) Biochemical Mechanisms; 
such as enzymatic inactivation, prevention of access to the target site by antibiotics and 
active efflux pumps. (2) Genetic mechanisms; such as mutation, horizontal gene trans-
fer and vertical gene transfer. Some factors identified to contribute to the emergence and 
dissemination of antibiotic resistant-Salmonella include; miss-used of antibiotics, used 
of antibiotics in agriculture, unregulated sales of antibiotics, inappropriate prescription 
and dispensing practices, and poor hygiene practices (external or behavioural factors), 
the presence of mobile genetic elements in the organisms; plasmid DNA, transposons, 
integrons etc. The clinical and public health consequences, and the   strategies to stem the 
growing tides associated with drugs resistance in Salmonella species are herein discussed. 
A more radical approach and commitment from the policy makers in health sector to solv-
ing problems emanating from increasing spread of resistant Salmonella is advocated.
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1. Introduction
Salmonella are Gram-negative, facultative anaerobes, rod-shaped bacteria and are trivially known 
as ‘enteric bacteria’ [1], with over 2587 serotypes. Salmonella are grouped into two basic species 
namely, Salmonella enterica and Salmonella bongori [2, 3]. Salmonella generally cause a disease 
© 2017 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
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termed salmonellosis, which are both typhoidal and non-typhoidal in nature. Moreover, investi-
gation of the molecular mechanisms of Salmonella virulence factors have shown that pathogenic 
Salmonella species are distinguished from non-pathogenic relatives by the presence of specific 
pathogenicity genes, often called pathogenicity island (PIs), which contributes to both natural 
and acquired resistance in Salmonella species [4, 5]. However, the ability of Salmonella to cause 
invasive infection varies with serovars, the age of the patient and environmental factors [6].
Drug resistance among Salmonella serotypes has been a public health concerns at global level 
[7]. This could be intrinsic (natural resistance) as seen in S. enterica serotype typhimurium 
definitive phage type (DT) 104 that contains the chromosomal Salmonella, genomic island type 
1 (SGI-1), which harbours resistance genes that confer ACSST phenotype (resistance to ampi-
cillin, chloramphenicol, streptomycin, sulphonamide and tetracycline) [8, 9]. Also, the intrinsic 
resistance could be as a result of impermeability of bacterial cell wall to antibiotic of interest [9]. 
Several factors have been identified to contribute to the acquired resistance in Salmonella, which 
include: inappropriate use of antibiotic (either through over-prescription, incomplete course 
of treatment or inadequate dosing, etc.), use of antimicrobial agents in agriculture (either as 
growth promoter or for prophylaxis purposes), hospital, mutation and transferable genetic 
materials (plasmid, transposons and integron) [1, 9, 10]. These factors are responsible for the 
acquisition (emergence) and dissemination (spread) of resistance in Salmonella species. Various 
mechanisms of antimicrobial inactivation exist in Salmonella spp., which lead to the emergence 
of multi-drug resistance (MDR) strains [11, 12]. Some of these mechanisms are as follows:
(i) Enzymatic inactivation of the drug (e.g. β-lactamase)
(ii) Prevention of access to the target agent
(iii) Change or mutation in the target site
(iv) Novel penicillin binding protein (PBPs)
(v) Altered membrane permeability
(vi) Active efflux pumps
(vii) Ribosome alteration
(viii) Creation of biofilm barriers, etc.
Mobile genetic elements such as plasmids, transposons and integrons play an important role 
in the evolution (emergence) and dissemination (spread) of multi-drug resistance by either 
horizontal or vertical gene transfer [13]. The role of integrons in the acquisition and dissemina-
tion of resistance in Salmonella species is crucial. Integrons are DNA elements that contain col-
lection of genes (gene cassette). Integrons are frequently associated with plasmid, transposon 
and are therefore easily transferable among Salmonella and/or between different bacteria [14].
The presence of virulence encoded plasmid DNA spvA, spvB and spvC in several Salmonella 
serovars had been documented and the outer membrane proteins (OMPs) of Salmonella 
typhimurium have a role in the virulence of the organism and are potent candidate for vac-
cine development since it is immunogenic, capable of evoking both humoral and cell-medi-
ated immune response. These OMPs indirectly play part in intrinsic resistance and can be 
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disseminated between or among Salmonella species [15, 16]. Thus, resistance acquisition or 
dissemination in Salmonella species usually involves several factors [1, 13].
2. Salmonella virulence and mechanisms of resistance
2.1. Salmonella and its virulence factors
The ability of Salmonella to attach itself to the host, invade and penetrate intestinal epithe-
lial cell is determined by its virulence factor [17]. Adherence of Salmonella is often mediated 
by fimbriae and/or non-fimbrial adhesion (lipopolysaccharide) [11]. Invasion process is not 
merely a passive consequence of bacterial contact with epithelial cells, but instead requires 
the active production and transport of secreted effector proteins by a Type III secretion system 
(T3SS) 1 & 2 and Type 1 secretion systems, which are encoded in Salmonella pathogenicity 
island I & 2 (SPI-I & 2), respectively [17]. In addition, invasion is also induced by flagella/
flagellin since Salmonella is a flagellated facultative anaerobe. Many invasion regulators have 
been described, for examples, HilA [18], HilC [19], InvF [20], PhoP/PhoQ, HilE [21], H-NS [19] 
and InvA genes, PhoP/PhoQ pair is also essential for the expression of genes in Salmonella 
pathogenicity island 2 (SP1-2), which encodes a second Type III secretory system. SP1-2 is 
required for intra-macrophage survival, which is a cell-type encountered by Salmonella imme-
diately after the invasion of epithelium. PhoP/PhoQ also serves to repress SP1-1 genes, a func-
tion mediated by HilA [22]. PhoP/PhoQ may thus act as a genetic switch, activating traits 
required for macrophages survival while repressing those not needed for invasion [17].
Other factors that are involved in Salmonella virulence are the MgtC in Salmonella typhimurium. 
This is required for growth at low—Mg2+ concentrations and intra-macrophage survival. Iron 
acquisition (for iron deprivation survival) this is achieved by the production of two siderophores, 
which are enterobactin and salmochelin in response to iron deprivation. Superoxide dismutase is 
used to counteract the reactive oxygen produced through the activity of the phagosome NADPH 
oxidase (NOX₂) that are required for the killing of intracellular pathogens and enterotoxin (respon-
sible for food-intoxication) [23]. The genes coding for the above-mentioned factors and others are 
conserved in Salmonella pathogenicity island 3 (SP1-3), and is also present in the chromosomes of 
other Salmonella enterica serovars [23]. It has been reported by several researchers [15, 24, 25], that 
stn genes coding for Salmonella enterotoxin) sef genes for Salmonella Enteritidis fimbriae, and pef 
genes for plasmid encoded fimbriae are widely distributed in resistant Salmonella strains and are 
responsible for Salmonella-associated diseases in animal and human populations globally.
2.2. Resistance mechanisms exhibited by Salmonella species to some antibiotics
Various mechanisms of anti-microbials inactivation have been reported by [11, 26], which 
invariably lead to the emergence of multidrug resistance in Salmonella species. These mecha-
nisms are summarized into two broad groups, namely:
• Biochemical mechanisms and
• Genetics mechanisms.
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2.2.1. Biochemical mechanisms of antibiotic resistance by Salmonella species
Enzymatic inactivation: This may result into either destruction of antimicrobial agents, such as 
occurs with the β-lactamases, or lead to a major modification of the antibiotic so that it does 
not bind to its target as it’s seen with the aminoglycoside and chloramphenicol [1]. The major 
mechanisms of resistance to beta-lactam antibiotics among Enterobacteriaceae involve produc-
tion of β-lactamase or extended spectrum β-lactamase (ESBLs) [1]. ESBLs have traditionally 
been defined as transmissible β-lactamases that can be inhibited by clavulanic acid, tazobactam 
or sulbactam. They are group of enzymes that break down antibiotics belonging to the penicil-
lin and cephalosporin groups and render them ineffective [1]. ESBLs are generally encoded by 
mobile genes that can be exchanged between bacteria [27]. It has been noted that when ESBL 
strains occur, they often have co-resistance with the aminoglycosides (gentamicin), tetracy-
cline and trimethoprim/sulphamethoxazole [27]. CTX–M ESBLs arise by plasmid acquisition 
of pre-existing chromosomal ESBL genes; this proved that ESBL can be plasmid mediated and 
thus capable of spreading to other microorganisms of either related species or genera [28].
Prevention of access to the target site: This may be by substitutions, amplifications or modifica-
tion of the drug target, thereby reducing the affinity of the drug to the target. For example, 
in Salmonella, the outer membrane proteins may be altered such that antibiotics are unable 
to cross its cell wall [26]. Gram-negative bacteria can regulate membrane permeability by 
altering expression of outer membrane porin (omp) proteins that form channels for passive 
diffusion. Loss or reduced levels of ompF has been implicated in anti-microbial resistance in 
Salmonella over the years [29].
Active efflux pumps: This involves the expellant of multiple kinds of antibiotics out of the 
cytoplasm of the microorganism to the external environment [11]. Increased expression of 
non-specific, energy-dependent efflux systems allow bacteria to prevent the accumulation 
of effective concentrations of quinolones inside the cell by actively pumping out the drug. In 
Escherichia coli, the AcrAB-TolC efflux pump plays a major role in quinolone efflux and studies 
suggest that this may be the primary mechanism of fluoroquinolone resistance in Salmonella 
[30]. It is thoughtful that these efflux systems cause low-level resistance to quinolones that can 
become clinically relevant when combined with mutations in the target enzymes [31].
Reduced permeability of the antimicrobial agent: This is a common mechanism of anti-microbial 
resistance usually exhibited my S. enterica. It involves the alteration in membrane permeabil-
ity, which occurs when new genetic information, change the nature of proteins in the mem-
brane. This alteration changes a membrane transport system pores in the membrane for an 
anti-microbial agent not to be able to cross the membrane. This form of resistance mechanism 
has been discovered in Salmonella typhi to tetracycline, quinolones and some aminoglycosides 
and sulphonamide antibiotics [32, 33].
2.2.2. Genetics mechanisms of antibiotics resistance in Salmonella species
The genes coding for antibiotics resistance and virulence at times share common features of 
being located in the bacterial chromosome, as well as on plasmid (Tables 1 and 2). They are 
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associated in gene clusters to form resistance or pathogenicity island, which are transferred 
by mobile genetic elements such as integrons, transposons or phage [34].
The major genetics mechanisms are as follows:
• Mutation
• Horizontal resistant gene transfer and
• Vertical resistant gene transfer.
Resistance in enteric bacteria: Salmonella, E. coli, Shigella, spp. etc., can be a result of gene muta-
tion (a permanent change in the DNA of an organisms), which had been detected through sev-
eral research studies globally or transfer of resistance determinant (R-determinants) between 
the same species or different species (Horizontal gene transfer) or by transfer of resistance 
genes from parental microorganism to its progeny or offspring (Vertical gene transfer) [13, 35]. 
Clinically, chromosomal and plasmid-mediated resistance in Salmonella to gentamicin and Beta-
lactam antibiotics had been reported in some host animal and humans [35–37].
The role of integrons in the acquisition and dissemination of resistance in enteric bacteria 
such as Salmonella is very crucial. Integrons are genetic elements that capture and incorporate 
gene cassettes by using a site-specific recommendation mechanism [38]. The class 1 and class 
2 integrons are known to play specific role in anti-book resistance in Salmonella spp., which 
usually contain conserved segments. For example, integron class 1 has been reported to carry 
aadA
2
, bla and pse1 cassette [39, 40]. Most of these integrons are located within transposons 
that contribute to vertical transmission, favouring their mobilization between plasmid and 
Antibiotic group Members Effect Mechanism of actions
β-Lactarns Penicillin(s), Amoxicillin Imipenem 
Cephalosporin (1st, 2nd, 3rd 
generation)
Cidal Inhibit transpeptidation enzymes involved 
in cross-linking the poly saccharide chains 
of the bacterial cell wall peptidoglycan and 
also by activation of cell wall lytic enzymes 
(cell wall synthesis inhibition)
Aminoglycoside Neomycin, Kanamycin, Amikacin, 
Tobramycin, Gentamycin and 
Streptomycin
Cidal Bind to small ribosomal sub-unit (30s) 
and interfere with protein synthesis by 
directly inhibiting synthesis and causing 
misreading of mRNA. Thereby inhibiting 
protein synthesis
Tetracycline Oxytetracycline, Chlortetracycline, 
Doxycycline, etc.
Static Same as aminoglycoside
Quinolones and 
fluoroquinoles
Ciprofloxacin, Norfloxacin, etc. Cidal Inhibit DNA gyrase and topoisomerase II, 
thereby blocking DNA replication
Sulfonamides Silver-sulphadiazine, 
Sulphamethoxazole, Sulphanilamide, 
Sulphisoxazole, etc.
Static Inhibits folic acid synthesis by competing 
with p-aminobenzoic acid (PABA)
Adapted from Refs. [1, 40].
Table 1. Properties of some common antibacterial drugs commonly used against Salmonella species.
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the bacterial chromosome by transposition events [14]. They have the ability to integrate sta-
bly into regions of other DNA, where they deliver, in a single exchange multiple new genes, 
particularly for drug resistance [41]. Many of the gene cassettes in resistance integrons, prob-
ably originated from super-integron (larger integron structures with hundreds of accessory 
genes), which encode for resistance against newer antibiotics such as cephalosporin and car-
bapenems [22].
2.3. Antibiotics commonly used for the treatment of salmonellosis and their  
mechanisms of actions
Some groups of antibiotics used in the treatment of salmonellosis globally for public health 
purposes as shown in Table 1 include:
Aminoglycosides: Salmonella resistance to aminoglycosides is usually by enzymatic modifica-
tion and binding to the 30S ribosomal subunit, resulting in the inhibition of protein synthesis 
Resistance genes Resistance genes 
location(s)
Resistance mechanisms Region(s) References
Aminoglycosides aacC(3), aacC(3’)-
IIa, aacC(6’), aacC2, 
aadA, aadA1, aadA2, 
aadA12, aadB, 
ant(3”)-Ia, aphAI, 
aphAI IAB, aph(3)-
Ii-iv, aph(3)-IIa, strA, 
strB
CH, P Enzymatic modification 
and inactivation of 
aminoglycoside
Across the Globe [33, 42]
β-Lactams ompC, ompF, 
blaCMY-2, blaPSE-1, 
blaTEM-1, blaSHV-1, 
blaOXA-1, 
blaNDM-1
CH, P β-Lactamases, ESBL, 
Modification of porin 
(ompF), Efflux of 
β-lactam(ompC)
Across the Globe [33, 42, 44]
Quinolones and 
floro-quinolones
GryA, GyrB, parC, 
parE,
CH, P Mutation in the 
Quinolones Resistance 
Determining Region 
(QRDR) GryA, GyrB, 
parC, pare
Across the Globe [30]
Tetracycline tet(A), tet(B), tet(C), 
tet(D), tet(G), and 
tet(H)
P Efflux pumps, 
Modification of rRNA 
target, Inactivation of 
compound
Across the Globe [33, 42, 45]
Sulphanamides Sul1, sul2 sul3, dfr CH, P Dihydropteroate 
synthase
Across the Globe [42–44]
Phenicol eg 
Chloramphenicol
floR, cmlA, cat1 CH, P Efflux pumps 
(floR, cmlA) and 
chloramphenicol 
acetyltransferase
Across the Globe [42, 45]
Table 2. Antibiotic resistance genes and resistance mechanisms found in Salmonella species.
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in the organism aminoglycoside phosphotransferase confirms resistance to Kanamycin and 
Neomycin. Major, resistance genes include strA, strB, aac, aad, etc. [42, 43].
Tetracycline: Tetracycline targets the 30S ribosomal subunit of the bacteria ribosome just as 
aminoglycosides. Resistance mechanisms include efflux, modification of rRNA and inactiva-
tion of the compound [43]. In Salmonella, active efflux systems are most commonly observed 
and it includes tetA, B, C, D, G and H [43].
β-lactams: β-lactams prevent synthesis and maintenance of the peptidoglycan component of 
the bacteria cell wall by mimicking one of the building blocks used by enzymes to construct 
peptidoglycan. Most resistance to β-lactams is confirmed by β-lactamase that enzymatically 
cleaves the β-lactams ring and prevents it from bonding to and inactivating cell wall enzymes. 
Furthermore, extended spectrum β-lactamase is an important group of β-lactamases newly 
discovered not more than one decade ago [44]. However, other resistance mechanisms 
reported in major regions across the globe include efflux of the β-lactams and modification of 
porin (e.g. ompF and ompC) [42, 45].
Phenicols: Phenicols, e.g. chloramphenicol and related compound such as florphenicol, inhibit 
protein synthesis by binding to the 50S ribosome subunit. Resistance to chloramphenicol is 
highly prevalence in developing countries based on its cheapness and easy accessibility in the 
counter e.g. Nigeria [10, 44], despite its ban in developed countries, e.g. USA, based on it tox-
icity [43]. Most resistance mechanisms exhibited by Enterobacteriaceae including Salmonella are 
efflux pumps such as floR and cmlA as well as inactivating enzymes such as chloramphenicol 
acetyltransferase cat1 [46].
Sulphonamides: They are also called folate pathway inhibitors. These are compounds that com-
pete for substrate of the essential folic acid pathway in bacteria at two different steps, and the 
sulphanilamide inhibits DHPS (dihydrofolate reductase). Sulphonamides are bacteriostatic 
when used alone or bactericidal when combined with trimethoprim-sulphamethoxazole [47]. 
Resistance to both of these antimicrobials occurs by acquisition of gene-encoding enzymes 
that do not bind these compounds [43], these include, the sul genes eg sul1, sul2 and sul3, 
which encode for insensitive DHPs enzymes, and are found in Salmonella globally [46].
2.4. Phenotypic and genotypic detection of resistance in Salmonella
Drug or antibiotic resistance is the decreased sensitivity of microbes to drug or antibiotics that 
are capable of causing cell death or inhibition of growth [48]. This is determined through antimi-
crobial sensitivity testing of Salmonella species (isolates) in order to determine its susceptibility 
or resistance to the antibiotics [49]. Resistance in Salmonella is encoded by genes that are present 
on either chromosome or extra-chromosomal DNA (plasmid) or transferable genetic materials 
(transposons, integrons), which is determined by genetic or molecular method [50]. The most 
common method is the Kirby-Bauer method [49]. Although resistance may occur due to muta-
tion in key genetic loci in the bacterial genome, but most resistance to antimicrobial agents medi-
ated by genes are acquired via mobile genetic elements such as plasmid and transposons [50]. 
The identification of resistance genotype is accomplished through detection of novel genetic 
materials and characterization of mutations in specific genes through polymerase chain reaction 
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(PCR). Several genetic methods including DNA probes, PCR and other amplification techniques 
are now used in varieties of clinical laboratories for identification and quantification of patho-
genic organisms [51, 52].
2.5. Some identified factors for the emergence and spread of resistance in Salmonella 
species
The emergence of resistance is the natural response of microbes to the presence of anti-
microbial agents [53, 54]. Several factors contribute to the increase in multi-drug resistance by 
Salmonella species, which can be grouped into two, namely:
• Behavioural factors (external factors): which include misuse of antibiotics, use of antibiotics 
in agriculture, unregulated sales of antibiotics, inappropriate prescription and dispensing 
practices and poor hygiene practices.
• Genetics factors: the mobile genetic elements, which include plasmids, transposons, inte-
grons, etc.
2.5.1. Behavioural factors
These involve attitudinal conduct of the prescribers (Doctors), dispensers (Pharmacist), 
patients, agriculturists and/or government to prescription, sales, usage and regulation of anti-
biotics. These are elucidated as follows:
Inappropriate prescribing and dispensing: Lack of access to update information makes prescrib-
ers to prescribe less rationally [55]. Economic incentive and enticement from pharmaceutical 
companies further pressure the prescriber to prescribe unnecessarily or inappropriately [56]. 
Moreover, it is a common practice in many developing countries for antibiotics to be dis-
pensed without a prescription. Also, over the counter sales of antibiotics is common. These 
practices had been attributed to weak enforcement of laws in such countries with resultant 
increase in acquisition of drug resistance in Salmonella species and high morbidity and mortal-
ity of Salmonella-associated diseases [10, 56].
Patients: Patient attitude contributes to the emergences of resistance through poor compli-
ance to the prescribed course of treatment [1], especially if their symptoms are mild and 
resolved quickly [57]. The attitudes of self-medication in most patients has seriously con-
tributed to the emergence of MDR in S. typhi to most first line drugs such as chloram-
phenicol, cephalosporin, streptomycin, tetracycline, ampicillin, etc. [10]. More also, poor 
hygiene practices of handling raw animal product and food in general with inadequate heat 
treatment has greatly contributed to the spread of antibiotic resistant strains from animal 
products and food to human [58, 59]. Furthermore, improper cooking methods; re-heating 
of food by food handlers in restaurants and canteens have been identified as also a major 
factor responsible for the spread of multidrug resistant Salmonella species since most of 
developing countries (e.g. Nigeria) population live below the average level of $1 per day 
meal, hence they resort to patronizing restaurants and canteens of questionable cooking 
standards [60, 61].
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Hospitals and laboratories (medical centres): Majority of antimicrobials usages occur in the com-
munity, of which most intense usage occurs in hospital [64]. The strong selective pressure 
together with the multitude of opportunities for resistant strains of Salmonella to spread 
from patient to patient is of high increase, this then means that hospital-acquired infections 
(Nosocomial infection) are mainly caused by multi-drug resistant strains, as seen in S. typhi 
in the case of typhoid fever [10]. Early discharges from hospitals either through changes in 
practice (e.g. cost reduction in developed countries) or lack of patient’s ability to pay (particu-
larly in developing countries) contribute to the emergence and dissemination of multi-drug 
resistance strains of Salmonella species [56]. However, hospitals work based on laboratory 
diagnosis must of the time not relying on clinical diagnosis alone since the former is the most 
reliable means of diagnosing a patient. But it is in the other way in developing countries 
based on exclusive reliance on Widal test as a means of diagnosing typhoid fever, which can 
be misleading as individuals with pyrexia are assumed and erroneously diagnosed as having 
typhoid fever based on single Widal agglutination test [62].
Government: contributes to the emergence of resistance in Salmonella species and other disease 
causing organisms that are of public health concern in the following perspective:
(1) Weakness in legislation or its enforcement contributes to resistance by allowing the circu-
lation in the market of substandard or counterfeit antimicrobials.
(2) Poor regulation of advertisement and promotion of drug undoubtedly increases sales, 
and encourages unnecessary use of antimicrobials.
(3) Lack of adequate training and certification of prescribers and dispensers may be due to 
poor provision or regulation by government.
(4) Poor availability of potable water.
(5) Poor diagnostic facilities of salmonellosis (typhoidal and non-typhoidal) in terms of iso-
lation of the causative agent for quality treatment.
(6) Poor sewage disposal and waste treatment channels.
It should also be noted, that lack of information about prevalence of resistance problems or 
poor supply chain management or long-term facilities (poor diagnostic facilities) contribute 
to poor diagnosis and effective treatment of disease that are of public health concern, which 
result in emergence of multi-drug resistance strains that eventually result to high cost of treat-
ment of these diseases [1, 10, 63]. Furthermore, non-availability of S. typhi vaccines in devel-
oping countries like Nigeria is also one of the contributing factors to the spread of resistance 
in Salmonella species [64].
Contribution of non-human uses of antimicrobials: The worldwide increase in the use of antibiot-
ics in poultry, fishery and livestock production industries to treat and prevent infections, or as 
growth promoter, has greatly contributed to the increased antibiotics resistance in potential 
food-borne pathogens (Salmonella, Shigella, Campylobacter, etc.) in the past years [58, 64]. The 
increased use of antibiotics in agriculture has played a significant role in the emergence and 
spread of antibiotic resistant food-borne pathogens in human as a result of the consumption 
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of poultry and dairy products [59]. The summary of the behavioural factors and their contri-
bution to antibiotic resistance is shown in Figure 1.
2.5.2. The genetic factors
The major mechanism in the spread (dissemination of resistance genes between or among bac-
teria of the same species or different species is through genetic mechanism. Since resistance 
genes for instance in Salmonella have often been located within plasmid, integrons sometimes 
Figure 1. A flow chart showing the spread of antibiotic resistance in Salmonella species in both man and animal 
populations.
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associated with transposons and also insertion sequence [1, 56, 65]. The major factors involved 
in the genetic mechanism of spread are the integrons, transposomes and plasmids [13].
Integrons are mobile genetic elements of specific structure that consist of two conserved seg-
ment capable of flanking through a central region in which resistance gene cassettes are 
inserted [36]. Also, on the 51-conserved segment is an int gene that encodes a site-specific 
recombinase, capable of capturing DNA, including resistance genes [66].
Transposons: These are mobile genetic elements that contain insertion sequence (0.2–6.0kb), 
which can move (transpose) from one site to the other site within the same or different chro-
mosome or plasmid and thus replicate along with it [56].
Plasmid (4–400kb) are self-replicating, extra chromosomal DNA that contain genes either 
for resistance, virulence and other functions and are dispensable under certain conditions. 
Incompatibility group of plasmid DNA (Inc) HI1 are important vectors of antibiotic resistance 
in S. typhi. It was first detected from a large outbreak in 1972 in Mexico [64]. However, some 
larger plasmids are conjugative (R-plasmid) and are transferable between organisms, spread-
ing along resistance genes in S. typhi [38]. It is should be noted that, as resistance genes move to 
other plasmids or chromosomes, they sometimes link with other resistance genes in resistance 
clusters, whose transfer can then result in spontaneous acquisition of resistance to several unre-
lated drugs, which eventually result to multi-drug resistance by recombination process [56].
2.6. Consequences of resistance in Salmonella species to public health
There are several clinical and public health consequences associated with antimicrobial drugs 
resistance in Salmonella species. These include:
(1) Failure in therapy, thereby resulting to limitation in the choice of treatment after the es-
tablishment of microbial diagnosis [67].
(2) Increased burden of illness and outbreaks in settings where patients are treated with 
antimicrobial drugs [67].
(3) Increased virulence of Salmonella species as a result of ‘drug-bug combination’ that poses 
selective pressure on the microorganism [25].
(4) Increased mortality and morbidity, thereby posing threats to public health [10, 67].
(5) Increased cost of treatments [1].
(6) Longer stay in hospital, which increases the risk of acquisition of nosocomial infections.
(7) Increased transmission of resistant Salmonella strains [67].
2.7. Strategies to combat resistance problems posed by Salmonella species
Several efforts have been adopted by several organizations, government and researchers to 
combat antimicrobial resistance imposed by some pathogenic organism that are of public 
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health significant (Salmonella spp.) [68]. The 2006 IFT report led to the publication of the World 
Health Organization (WHO) list of critically important antimicrobials for human medicine and 
veterinary importance. This propelled the U.S Food and Drug Administration (FDA) to catego-
rize various classes of anti-microbials as important, highly important and critically important 
and has since issued rules that prohibit most extra labelled use of some critically important 
antimicrobials such as fluoroquinolones and cephalosporin in food animal species [69].
Other efforts to address threats posed by antimicrobial resistance include: monitoring pro-
grammes for antimicrobial resistance microbes that integrates human, animals and food 
sampling scheme. Examples include: National Antimicrobial Resistance Monitoring System 
(NARMS) in the United States and the Danish Integrated Antimicrobial Resistance Monitoring 
Programme (DANMAP) in Denmark. These programmes in collaboration with CDC, WHO 
and FDA had really helped to trace the incidence of resistance particularly in foodborne patho-
gens (Salmonella and Campylobacter) globally, thereby embarking several strategies such as giv-
ing updated information, rules/laws, social and financial help, etc. to combat resistance threats.
Also, effort to combat resistance posed by Salmonella is the modification of drugs that led to the 
production of third – and fourth generation cephalosporins, and the use of medicinal plants also 
known as herbal medicine had been proven to have bactericidal effect on S. typhi; the causative 
agent of typhoid fever, also with the use of combined therapy, that is, the use of two or more 
different classes of antibiotics for the treatments of a particular disease e.g. Salmonellosis [1, 57].
Furthermore, the following are also needed to be done to track-down the current rise in the 
spread of resistant S. enterica: Intensive surveillance of vended foods in developing coun-
tries to reduce microbial risk associated with their consumption [60]. Public enlightenment 
to discourage the patronage of vended foods should be intensified as vended foods espe-
cially in Lagos is a potential vector responsible for the spread of resistant Salmonella spe-
cies, or high level of hygiene practice should be maintained by food vendors under strict 
supervision and monitoring by food regulatory authorities if at all vended foods will be 
patronized [60].
3. Conclusion
Several factors such as misuse of antibiotics, use of antibiotics in agriculture, poor hygiene 
practices by hospitals and individuals, unregulated sales of antibiotics and genetic factors, 
such as plasmids, integron, transposons, etc., contribute to selective pressure on antibiotics 
and resistance gene transfer, respectively, in Salmonella species. This has led to the emergence 
and spread of resistance in this microorganism and resultant therapeutic failures. Several 
strategies have been adopted by governmental organizations and pharmaceutical companies 
in the areas of resistance monitoring, restriction in the use of antibiotics in agriculture, pro-
duction of modified drugs, the use of combined therapy, future plans on the use of bioactive 
compounds from medicinal plants against MDR bacterial strains. There is a need to enforce 
regulatory laws governing procurement and sales of antibiotics in developing countries. 
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Also, good sanitation and hygiene practices as well as sensitization of people about the dan-
ger associated with indiscriminate purchase and use of antibiotics are essential to steam the 
growing trends of antibiotic resistance in bacterial pathogens especially Salmonella species.
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